Close Menu

cancer panel

So far, results from the MSK-IMPACT test have been reported for more than 4,500 patients.

The UCSF spinout was founded last year and has been selling an FFPE DNA extraction kit and three NGS cancer panels.

The company has established a streamlined workflow that customizes and automates key steps of the sample prep process.

GATC Biotech will sell and market Molecular Health's TreatmentMap next-generation sequencing-based tumor profiling platform around the world.

Despite the findings of the Hopkins study, for practical and economic reasons many diagnostic laboratories currently only sequence tumor samples or do not believe the tumor-normal approach is necessary.

The firm will launch an onsite version of its clinical decision support system this year and expects to add tumor profiling services next year.

The partners will use New Oncology's Neo platform to analyze therapeutically relevant alterations in cancer patients' DNA.

NEW YORK (GenomeWeb) — Researchers from the Vanderbilt University Medical Center have released a retrospective study showing that Foundation Medicine's FoundationOne test identified a potentially actionable mutation in the majority of the first 103 cancer patients to receive the test at the cente

NEW YORK (GenomeWeb) — OncoDNA, a clinical NGS provider affiliated with the Institute of Pathology and Genetics in Gosselies, Belgium, announced last week that it is providing targeted sequencing of metastatic breast cancer patients for a large international effort called AURORA, led by the Breas

Genewiz, a contract research organization specializing in sequencing and other genomic services, has announced that it is branching out into the clinical sequencing and personalized medicine space with two sequencing panels — a 25-gene general pharmacogenomic panel and a 35-gene

Pages

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.